腹腔镜胆囊切除术对比经皮穿刺引流治疗高危急性胆囊炎(CHOCOLATE):多中心随机临床试验
该多中心随机对照优效性试验纳入142例高危急性结石性胆囊炎患者(APACHE II≥7),比较腹腔镜胆囊切除术与经皮穿刺引流的疗效。结果显示,主要并发症发生率在胆囊切除术组为12%,引流组为65%(RR 0.19,95%CI 0.10-0.37,P<0.001),但一年死亡率无显著差异。结论提示腹腔镜胆囊切除术可降低高危患者的主要并发症发生率。
要点
- 高危急性胆囊炎患者行腹腔镜胆囊切除术,主要并发症发生率显著低于经皮穿刺引流。
- 引流组再干预率和胆道疾病复发率均显著更高。
- 两组一年死亡率无显著差异。
核心结论
- 与经皮穿刺引流相比,腹腔镜胆囊切除术降低了高危急性胆囊炎患者的主要并发症发生率。
研究设计与样本
- 多中心、随机对照、优效性试验,在荷兰11家医院开展,2011年2月至2016年1月。
- 共纳入142例高危急性结石性胆囊炎患者,随机分配至腹腔镜胆囊切除术组(n=66)或经皮穿刺引流组(n=68)。
- 高危定义为急性生理学与慢性健康状况评分II(APACHE II)≥7。
主要发现
- 腹腔镜胆囊切除术组与经皮穿刺引流组的一年死亡率分别为3%和9%(P=0.27)。
- 主要并发症在胆囊切除术组发生8/66例(12%),在引流组发生44/68例(65%)(风险比0.19,95%置信区间0.10-0.37;P<0.001)。
- 引流组45例(66%)需要再干预,而胆囊切除术组8例(12%)需要再干预(P<0.001)。
- 引流组胆道疾病复发率更高(53% vs 5%,P<0.001),中位住院时间更长(9天 vs 5天,P<0.001)。
关键数值与推荐
- 主要终点为一年内死亡和主要并发症的发生,主要并发症定义为一个月内的感染性和心肺并发症、一年内需再干预(与急性胆囊炎相关的手术、放射或内镜干预)或一年内胆道疾病复发。
- 高危定义为APACHE II评分≥7。
- 试验在计划的中期分析后提前终止。
临床怎么用
- 对于APACHE II评分≥7的高危急性结石性胆囊炎患者,腹腔镜胆囊切除术可作为优先考虑的治疗策略,以降低主要并发症风险。
局限性
- 试验因中期分析结果而提前终止,可能影响结果的精确性。
- 样本量较小(共142例),可能限制亚组分析或普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether laparoscopic cholecystectomy is superior to percutaneous catheter drainage in high risk patients with acute calculous cholecystitis. DESIGN: Multicentre, randomised controlled, superiority trial. SETTING: 11 hospitals in the Netherlands, February 2011 to January 2016. PARTICIPANTS: 142 high risk patients with acute calculous cholecystitis were randomly allocated to laparoscopic cholecystectomy (n=66) or to percutaneous catheter drainage (n=68). High risk was defined as an acute physiological assessment and chronic health evaluation II (APACHE II) score of 7 or more. MAIN OUTCOME MEASURES: The primary endpoints were death within one year and the occurrence of major complications, defined as infectious and cardiopulmonary complications within one month, need for reintervention (surgical, radiological, or endoscopic that had to be related to acute cholecystitis) within one year, or recurrent biliary disease within one year. RESULTS: The trial was concluded early after a planned interim analysis. The rate of death did not differ between the laparoscopic cholecystectomy and percutaneous catheter drainage group (3% v 9%, P=0.27), but major complications occurred in eight of 66 patients (12%) assigned to cholecystectomy and in 44 of 68 patients (65%) assigned to percutaneous drainage (risk ratio 0.19, 95% confidence interval 0.10 to 0.37; P<0.001). In the drainage group 45 patients (66%) required a reintervention compared with eight patients (12%) in the cholecystectomy group (P<0.001). Recurrent biliary disease occurred more often in the percutaneous drainage group (53% v 5%, P<0.001), and the median length of hospital stay was longer (9 days v 5 days, P<0.001). CONCLUSION: Laparoscopic cholecystectomy compared with percutaneous catheter drainage reduced the rate of major complications in high risk patients with acute cholecystitis. TRIAL REGISTRATION: Dutch Trial Register NTR2666.
引用
- Loozen CS, van Santvoort HC, van Duijvendijk P, et al. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ. 2018. PMID: 30297544. doi:10.1136/bmj.k3965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。